{ "@type": "Dataset", "name": "@NarjustFlorezMD on X", "description": "Followers, posts and engagement for @NarjustFlorezMD.", "url": "https://tweetindex.com/account/NarjustFlorezMD", "isAccessibleForFree": true, "creator": { "@id": "https://tweetindex.com/#organization" }, "variableMeasured": [ { "@type": "PropertyValue", "name": "Followers", "value": 25472 }, { "@type": "PropertyValue", "name": "Following", "value": 2050 }, { "@type": "PropertyValue", "name": "Posts", "value": 24829 }, { "@type": "PropertyValue", "name": "Collected posts", "value": 6 }, { "@type": "PropertyValue", "name": "Views on collected posts", "value": 6357 }, { "@type": "PropertyValue", "name": "Likes on collected posts", "value": 65 } ], "distribution": [ { "@type": "DataDownload", "contentUrl": "https://tweetindex.com/api/accounts/NarjustFlorezMD", "encodingFormat": "application/json" } ], "@id": "https://tweetindex.com/account/NarjustFlorezMD#dataset" }

Narjust Florez, MD, FASCO ✓

@NarjustFlorezMD · Boston, MA · joined 21 Apr 2017

Thoracic Medical Oncologist @DanaFarberNews & @Harvardmed | Young Lung Cancer | Editor @Jamaonc | Co-founder @LatinasInMed | Personal views only.

25 472Followers

2 050Following

24 829Posts total

6.4KViews on collected posts

Derniers posts

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD5 Sep

He knows! 725 views · 4 likes · 0 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

@NarjustFlorezMD @StephenVLiu @IASLC Skincare and fried chicken! What's not to like? 762 views · 3 likes · 0 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Are you going to #WCLC26? You MUST listen to this episode of Lung Cancer Considered https://t.co/xdjLPACb7Q @StephenVLiu @IASLC https://t.co/7PtDCfMzqf 759 views · 16 likes · 0 reposts · 1 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Are you ready for #WCLC26? In this episode of Lung Cancer Considered we tell you all you need to know - from packing to your return home. @StephenVLiu @IASLC https://t.co/xdjLPACb7Q 798 views · 8 likes · 5 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Before You Go: A Practical Guide to WCLC 2026 in Seoul EVERYTHING YOU NEED TO KNOW BEFORE #WCLC26 New episode of lung cancer considered @StephenVLiu https://t.co/xdjLPACb7Q 807 views · 10 likes · 2 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD2 Jun

RET fusion–positive NSCLC just got its adjuvant targeted therapy LIBRETTO-432 is published in NEJM and the data are practice-changing. 🎯 Watch our clinical perspective below #ASCO26 Full publication: https://t.co/6YOeUhFO3n @RETpositive @YoungLungCancer @OncogeneCancer https: 2.5K views · 24 likes · 6 reposts · 1 replies Open on X →

Face aux comptes de taille comparable

5 posts des 90 derniers jours, à côté de la tranche de 10K–100K abonnés. juste au niveau de la médiane de sa tranche d'abonnés.

Vues médianes762ce compte924médiane pour 10K–100K

Portée, %2.99%ce compte3.62%médiane pour 10K–100K

Engagement, %1.49%ce compte1.52%médiane pour 10K–100K

Indicateur	Ce compte	Médiane pour 10K–100K	Rapport
Vues médianes par post	762	924	0.82×
Portée (vues ÷ abonnés)	2.99%	3.62%	0.83×
Taux d'engagement	1.49%	1.52%	0.98×

Autres comptes de cette tranche → Comparer avec un autre compte → Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.